Karl E. Griswold
Impact in
- Biotechnology top 5%
- Transgenic Plants and Applications
- Microbiology top 5%
Papers in
-
- vaccines and immunoinformatics approaches 16
- Biochemical and Structural Characterization 6
-
- Monoclonal and Polyclonal Antibodies Research 19
- Co-authors
- Chris Bailey‐Kellogg (26 shared papers)Yoonjoo Choi (12 shared papers)Thomas C. Scanlon (9 shared papers)Andrew S. Parker (7 shared papers)Brent L. Iverson (3 shared papers)George Georgiou (3 shared papers)Deeptak Verma (6 shared papers)Christian Ndong (10 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Journal of Computational Biology (3 papers)PLoS ONE (3 papers)Biotechnology and Bioengineering (3 papers)PLoS Computational Biology (3 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Karl E. Griswold
63 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Biotechnology 192
- Microbiology 110
- Molecular Medicine 81
- Radiology, Nuclear Medicine and Imaging 301
- Molecular Biology 947
Countries citing papers authored by Karl E. Griswold
This map shows the geographic impact of Karl E. Griswold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl E. Griswold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl E. Griswold more than expected).
Fields of papers citing papers by Karl E. Griswold
This network shows the impact of papers produced by Karl E. Griswold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl E. Griswold. The network helps show where Karl E. Griswold may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl E. Griswold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 92 | |
| 2 | 2012 | 91 | |
| 3 | 2013 | 78 | |
| 4 | 2013 | 73 | |
| 5 | 2015 | 48 | |
| 6 | 2013 | 46 | |
| 7 | 2005 | 44 | |
| 8 | 2015 | 44 | |
| 9 | 2016 | 43 | |
| 10 | 2010 | 41 | |
| 11 | 2010 | 41 | |
| 12 | 2005 | 39 | |
| 13 | 2014 | 37 | |
| 14 | 2016 | 35 | |
| 15 | 2015 | 35 | |
| 16 | 2012 | 33 | |
| 17 | 2006 | 33 | |
| 18 | 2017 | 31 | |
| 19 | 2014 | 31 | |
| 20 | 2016 | 30 |
About Karl E. Griswold
Karl E. Griswold is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Biotechnology, Ecology and Biomedical Engineering, having authored 63 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (19 papers), vaccines and immunoinformatics approaches (16 papers), Bacteriophages and microbial interactions (13 papers), Transgenic Plants and Applications (8 papers), Biochemical and Structural Characterization (6 papers), Bacterial Genetics and Biotechnology (6 papers), Antimicrobial Peptides and Activities (6 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Biotechnology (192 citations), Microbiology (110 citations), Molecular Medicine (81 citations), Radiology, Nuclear Medicine and Imaging (301 citations) and Molecular Biology (947 citations). Karl E. Griswold has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Chris Bailey‐Kellogg, Yoonjoo Choi, Thomas C. Scanlon, Andrew S. Parker, Brent L. Iverson, George Georgiou, Deeptak Verma, Christian Ndong, Hongliang Zhao and Warren C. Kett. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Computational Biology, PLoS ONE, Biotechnology and Bioengineering and PLoS Computational Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.